Cannabis News and Research

Latest Cannabis News and Research

Synthetic cannabinoid molecule created for osteoarthritis

Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

7 Jan 2014

MassRoots closes $150,000 in seed investment from members of ArcView Group

MassRoots, the social network for the medical cannabis community, is pleased to announce it has closed $150,000 in seed investment from members of the ArcView Group. The funding comes on the heels of MassRoots surpassing 25,000 active users and facilitating more than 28 million photo views in the month of December alone.

3 Jan 2014

Molecule produced by brain acts as natural defence mechanism against cannabis

Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.

3 Jan 2014

Prescription drug misuse and driving after using drugs on the rise among Ontario students

Alcohol consumption and smoking among Ontario students in grades 7-12 is at an all-time low; however recreational use of over-the-counter drugs is on the rise. Prescription drug misuse and driving after using drugs also remain elevated according to the 2013 Ontario Student Drug Use and Health Survey released by the Centre for Addiction and Mental Health.

16 Dec 2013

Quitting cannabis improves psychosis treatment adherence

Quitting cannabis appears to improve medication adherence in the long-term among patients admitted for first-episode psychosis, researchers have found.

13 Dec 2013

Cinnamon, nutmeg, marshmallows provide more than taste of holiday spice

Cinnamon, nutmeg and marshmallows provide more than a taste of holiday spice or a sugar rush. They are the ingredients for recipes for trendy risky games played by many to disasterous consequences.

13 Dec 2013

Adolescent brain remodeling goes awry in schizophrenia

A crucial reorganization process that occurs in the adolescent brain may be disturbed in those who go on to develop schizophrenia, a study suggests.

12 Dec 2013

New antimicrobial coating prevents infections during cold winter months

With cold and flu season now in full swing, all-natural wellness provider Neutra Corp. (OTCBB: NTRR) is working quickly to deliver a revolutionary new antimicrobial coating that could soon prove to be the best defense against infections and viruses in the most notorious hotspot for the spread of these diseases: the classroom.

11 Dec 2013

Garden-Gateway believes chronic sufferers can cope with holiday stress

The holidays are a time of high stress for all of us. This is especially true for the many Californians who suffer from chronic illness or disease. It's well documented that stress can aggravate a wide range of chronic ailments, both physical and psychological, such as back pain, cancer, PTSD or immune system deficiency.

30 Nov 2013

Purlife inks deal with Canada-based auto warranty company

Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, is proud to announce that its partner, Purlife, has signed a deal with one of Canada's largest automotive warranty companies to make its revolutionary Drivepur Protection System available to a network of 1,200 car dealerships.

26 Nov 2013

Environment plays primary role in psychosis transition

Research suggests that exposure to environmental risk factors may be necessary for individuals at genetically high risk for psychosis to transition from good health to the psychiatric disorder.

22 Nov 2013

Teenage cannabis use increases in developing countries

It's common to associate cannabis use with affluent youth in wealthy societies. But the relationship between societal and family affluence and cannabis use appears to be changing.

22 Nov 2013

Stroke may be associated with smoking synthetic marijuana

Add stroke to the list of severe health hazards that may be associated with smoking synthetic marijuana, popularly known as spice or K2, a University of South Florida neurology team reports.

20 Nov 2013

Studies prove that students use prescription drugs to enhance cognitive performance

American and European studies prove that students use prescription medication or drugs to enhance their cognitive performance. Researchers from the universities of Zurich and Basel examined whether Swiss students have also experimented with neuroenhancement and which substances they take by conducting a survey of 6,725 students with an average age of 23 at the two universities and ETH Zurich.

16 Nov 2013

Study identifies patterns of brain activity associated with eating disorders

A growing body of evidence shows the impact of diet on brain function, and identifies patterns of brain activity associated with eating disorders such as binge eating and purging. The findings were presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

14 Nov 2013

S2O2 finalizes acquisition of Texas-based sanitation technology innovator

Neutra Corp., a growing provider of all-natural wellness solutions, announced today that its joint venture partner Surface to Air Solutions is finalizing the acquisition of a sanitation technology innovator dedicated to greatly reducing the risk of staph infection in sports.

12 Nov 2013

Locker rooms from local high school to NFL, concern about spread of deadly infections

In locker rooms from your local high school to the National Football League, concern about the spread of potentially deadly bacteria and infections are leading training staffs to take extreme measures to prevent outbreaks. Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, could be close to offering a solution to the problem.

7 Nov 2013

Generic drug gabapentin appears to be safe, effective in treating alcohol dependence

The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute.

4 Nov 2013

New all-natural technology can eliminate molds and pesticides in cannabis products

As medical marijuana states crack down on pesticides, molds and other adulterants in cannabis products, Neutra Corp. is helping to develop new technology to keep patients safe from potentially harmful contamination.

30 Oct 2013

Regular cannabis users have increased levels of impulsive behaviour, reveals research

New cocaine and cannabis research reveals that regular cannabis users have increased levels of impulsive behaviour. It had previously been argued that this increased impulsivity after cannabis administration was only experienced by occasional users, but that regular users were no longer affected in this way.

29 Oct 2013